BIOTRONIK and University of Sydney Partner to Transform Cardiac Care Through Digital Innovation

• This Three-Year Collaboration Aims to Deliver Scalable Health Solutions for Improved Disease Management
• The Initiative Hopes to Benefit Patients Particularly in Remote or Underserved Regions with Limited Access to Care

BIOTRONIK, a global leader in medical technology, and the University of Sydney, one of the world’s top research and teaching institutions, have signed a Memorandum of Understanding (MoU) to jointly advance digital and connected health innovations through 2028.

By combining BIOTRONIK’s expertise in implanted cardiac devices and remote monitoring with the University of Sydney’s world-class research capabilities and the expertise of the Westmead Applied Research Centre (WARC) in patient-facing digital health tools, the collaboration aims to co-design solutions that address real-world clinical needs. This MoU marks a significant milestone in the evolution of patient-centered, value-based healthcare.

“This MoU is about more than just technology. It’s about reimagining how we deliver care,” said Jan Ewert, Managing Director, BIOTRONIK Australia and New Zealand. “We aim to create digital tools that integrate into existing workflows and empower clinicians and patients to improve care provision and outcomes.”

As healthcare systems worldwide face increasing pressure from rising costs, an ageing population, workforce shortages, the need for low-cost technology and digital solutions has never been more urgent. Smart, scalable solutions such as remote monitoring and AI-driven decision support can help bridge care gaps, optimize resources, and enable earlier interventions especially for chronic conditions.

Over the next three years, the partnership will focus on developing and clinically evaluating new tools in areas such as remote patient monitoring, AI, and clinical decision support. These innovations will be tested in real-world settings to ensure they deliver measurable value to both patients and healthcare systems. The initiative hopes to benefit patients particularly in remote or underserved regions with limited access to care.

“We are thrilled to deepen our relationship with BIOTRONIK to co-develop digital health solutions that are grounded in clinical evidence and designed with patient welfare at the heart,” said Professor Clara Chow AM, Professor of Medicine, Cardiologist (WSLHD), Academic Director (WARC) & Professor of Medicine at the Sydney Medical School. “It presents a unique opportunity to translate cutting-edge research into real-world impact for people living with cardiovascular disease.”

Cardiovascular disease remains the leading cause of death globally. Addressing this challenge requires cross-sector collaboration to translate research into practical, scalable solutions. This is aimed at accelerating progress, meeting the demands of modern healthcare.